After much dilly-dallying, the Centre has finally agreed to do away with Stavudine, having long-term irreversible side-effects, with a safer drug for HIV patients, even though the switchover will cost the government double the amount.
The World Health Organisation (WHO) had in 2010 recommended to phase out Stavudine due to its severe side effects.